Israeli Scientists Say Brain Analysis Tool Can Spot Cognitive Decline – Using Music

Times of Israel • August 26, 2022

Doctors today rely on face-to-face questions and answers to diagnose cognitive decline, but new peer-reviewed research suggests music may help make EEG-based testing viable.


Israeli scientists say they have developed a warning system for cognitive decline, which works by tracking brain function as elderly people listen to music.


With a three-electrode pad attached to their heads, people undergoing the test are asked to complete tasks, such as pressing a button when a particular instrument plays.


The pad is attached to a machine, which monitors brain function. An algorithm analyses the data to determine whether or not the brain function suggests that cognitive decline is underway, and if so, to what extent.


A Tel Aviv University PhD student, Neta Maimon, came up with the new 15-minute test, which has been trialed on dozens of elderly people in newly peer-reviewed research. The same people also underwent testing using standard assessment for cognitive decline, and the results from both tests largely matched.


She believes that after further development, assessment and regulatory approval, the test could “improve the quality of life of millions around the world” by providing more accessible screening than today’s cognitive tests, which are labor-intensive for doctors and normally reserved for people who already have concerns. Largely automated, she said that hers could be used as a routine test.

Cognitive decline relates to difficulties, beyond what are typically expected in aging, in a person’s brain functions such as thinking, memory and concentration.


“Our method enables the monitoring of cognitive capability and detection of cognitive decline in the early stages. It could do so by simple and accessible means, with a quick and easy test that can be conducted in any clinic,” Maimon said.


“Screening tests are commonly accepted for a variety of physiological problems such as diabetes, high blood pressure and breast cancer. But to date, no method has yet been developed to enable routine, accessible monitoring of the brain for cognitive issues.”


The study took place at Tel Aviv University’s School of Psychological Sciences and the Buchmann-Mehta School of Music, under the supervision of Prof. Nathan Intrator from the Blavatnik School of Computer Science and the Sagol School of Neuroscience.


Doctors normally diagnose cognitive decline by a face-to-face assessment that involves questions and tasks. There is a more objective method, but it involves a painful and invasive procedure to remove spinal fluid for testing. There is significant research toward a noninvasive objective method, some of it focused on magnetic resonance imaging (MRI) or scalp electroencephalogram (EEG), but no such method is in widespread use today.


Maimon uses an EEG machine to analyze the electrical activity in the brain as people complete her music test. A combination of the brain activity patterns and data on how quickly people completed tasks, like the button press when a particular instrument plays, gives scientists a strong indication of cognitive status.


The test uses an unusually-compact Israeli-made EEG machine, produced by the Neurosteer startup, which is headed by Intrator. Maimon says using a portable device makes her approach viable for mobile testing in elderly homes and clinics.

Maimon said that the approach needs further development and assessment, but could hold great potential.


“Today, millions of people around the world already suffer or are liable to suffer soon from cognitive decline and its dire consequences, and their number will only increase in the coming decades,” she said.


“Our method could pave the way towards efficient cognitive monitoring of the general population, and thus detect cognitive decline in its early stages, when treatment and prevention of severe decline are possible.”


– Nathan Jeffay, Times of Israel


MORE INFO

August 15, 2024
Under the direction of signal processing expert Nathan Intrator, PhD, Neurosteer’s team has created an affordable and accessible device that measures minute electrical brain activity. Their device can help patients and providers manage brain conditions more effectively and proactively.
May 21, 2024
Neurosteer has been selected into a small group out of 100+ companies that were identified as key players in the detection and treatment of Alzheimer’s. The Alzheimer’s Moonshot initiative is backed by $100M from Gates, Bezos, Lauder, the Dolby Foundation, and the Alzheimer's Drug Discovery Foundation (ADDF).
December 19, 2023
Neurosteer Inc. announces the publication of our groundbreaking paper in Frontiers in Neurology detailing a revolutionary approach to Parkinson's disease detection and differentiation using our pocket-sized hdrEEG™ system and a rapid 15-minute auditory assessment.disorders.
September 1, 2023
Neurosteer founder and CEO, Nathan Intrator PhD, has been invited to be a main speaker at the ApplySci AI + Deep Tech + NeuroTech conference at MIT later this month.
June 20, 2023
In “This Is What Music Does to Your Brain,” Yael Hallak of Haaretz writes that new research is exploring how to use music to bring people closer and even to diagnose cognitive decline in the elderly.
November 3, 2022
Neurosteer Inc. announces FDA clearance of its Neurosteer® single-channel EEG brain monitoring platform. The clearance allows Neurosteer’s unobtrusive multi-purpose system to be used in a broad range of clinical settings, including the ICU, a doctor’s office, and pharma drug trials.
By Neurosteer October 23, 2022
Neurosteer participated in Peter Gabriel’s event at the Fotografiska Museum in NYC, demonstrating the effect of music and meditation on the brain using real-time graphics by displaying brain activity as it related to the intensity of focus, relaxation, and emotion.
By Roche & Startup Nation Central July 14, 2022
Neurosteer was the winner of the Roche for a Better Future: Alzheimer’s Innovation Challenge , launched by Roche and Start-Up Nation Central with the vision of early detection and enhanced digital health support for Alzheimer’s disease patients and their caregivers.
By Neurosteer December 15, 2019
Neurosteer received the “Brain Health Company of the Year” award from Tradex News . It has been a great year for us, most notably in improving our product for early screening of Alzheimer’s, Parkinson’s and fronto-temporal dementia.
By Neurosteer November 19, 2019
Following recent fMRI studies on the effect of music on the brain, Israeli TV Channel 13 interviewed Neta Maimon , a PhD student in music cognition at Tel Aviv University and a researcher at Neurosteer. Using Neurosteer sensing technology on a group of brain-monitored study participants, emotional and cognitive responses to songs were clearly visible. 
More Posts
Share by: